OA07236A - Dérivés de la triazine, procédés pour leur préparation, et compositions pharmaceutiques comportant ces dérivés. - Google Patents
Dérivés de la triazine, procédés pour leur préparation, et compositions pharmaceutiques comportant ces dérivés.Info
- Publication number
- OA07236A OA07236A OA57828A OA57828A OA07236A OA 07236 A OA07236 A OA 07236A OA 57828 A OA57828 A OA 57828A OA 57828 A OA57828 A OA 57828A OA 07236 A OA07236 A OA 07236A
- Authority
- OA
- OAPI
- Prior art keywords
- derivatives
- processes
- preparation
- pharmaceutical compositions
- triazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8131900 | 1981-10-22 | ||
| GB8224151 | 1982-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA07236A true OA07236A (fr) | 1984-04-30 |
Family
ID=26281042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA57828A OA07236A (fr) | 1981-10-22 | 1982-10-22 | Dérivés de la triazine, procédés pour leur préparation, et compositions pharmaceutiques comportant ces dérivés. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4616014A (fr) |
| EP (1) | EP0077983B1 (fr) |
| JP (1) | JPS5899468A (fr) |
| AU (1) | AU8926982A (fr) |
| DE (1) | DE3276164D1 (fr) |
| DK (1) | DK453882A (fr) |
| ES (3) | ES8401042A1 (fr) |
| FI (1) | FI823544A7 (fr) |
| GR (1) | GR76714B (fr) |
| NO (1) | NO823506L (fr) |
| OA (1) | OA07236A (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1199027A (fr) * | 1981-11-12 | 1986-01-07 | Stuart D. Mills | Derives heterocycliques de pyridazinone, thiadiazinone, oxadiazinone et triazinone |
| US4581356A (en) * | 1983-03-22 | 1986-04-08 | Fujisawa Pharmaceutical Co., Ltd. | Triazine derivatives, and pharmaceutical compositions comprising the same |
| JPS59196874A (ja) * | 1983-04-22 | 1984-11-08 | Fujisawa Pharmaceut Co Ltd | トリアジン誘導体 |
| GB8328757D0 (en) * | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB8612796D0 (en) * | 1986-05-27 | 1986-07-02 | Fbc Ltd | Fungicides |
| US4970210A (en) * | 1987-07-17 | 1990-11-13 | Abbott Laboratories | Triazinone lipoxygenase compounds |
| CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
| IT1318392B1 (it) * | 2000-03-15 | 2003-08-25 | Getters Spa | Composizione getter di idrogeno. |
| KR100840883B1 (ko) | 2000-10-27 | 2008-06-24 | 다우 아그로사이언시즈 엘엘씨 | 치환된 4,5-디하이드로-1,2,4-트리아진-3-온 및 1,2,4-트리아진-3-온, 이들을 포함하는 살진균 및 살충 조성물, 및 이러한 조성물을 이용한 진균 및 곤충의 방제방법 |
| EP1340743A4 (fr) | 2000-11-09 | 2007-04-25 | Mitsui Chemicals Inc | Derive d'amine optiquement actif et methode de synthese |
| US20030236259A1 (en) * | 2002-02-05 | 2003-12-25 | Rolf Hohlweg | Novel aryl- and heteroarylpiperazines |
| CA2490470A1 (fr) * | 2002-07-02 | 2004-01-15 | Schering Corporation | Antagonistes du recepteur y y5 de neuropeptide pyrazole |
| US7323455B2 (en) * | 2004-03-24 | 2008-01-29 | Wyeth | 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators |
| RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| EP2386554A1 (fr) * | 2005-07-04 | 2011-11-16 | High Point Pharmaceuticals, LLC | Composés actives sur le recepteur histamine H3 |
| JP2009537596A (ja) * | 2006-05-23 | 2009-10-29 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用 |
| EP2079732B9 (fr) * | 2006-05-29 | 2012-03-21 | High Point Pharmaceuticals, LLC | 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyradine, ses sels et solvates et son utilisation comme antagoniste du recepteur d'histamin h3 |
| EP2014656A3 (fr) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | Nouveaux antagonistes d'hétéocycliques h3 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
| GB1604085A (en) * | 1977-05-17 | 1981-12-02 | Diamond Shamrock Corp | Pharmaceutical preparations containing 1,2,4-triazine derivatives |
| EP0052442B1 (fr) * | 1980-11-14 | 1985-09-11 | Imperial Chemical Industries Plc | Composés hétérocycliques |
| US4495185A (en) * | 1981-11-12 | 1985-01-22 | Imperial Chemical Industries, Plc | 1,2,4-Triazin-3(2H) ones |
| US4581356A (en) * | 1983-03-22 | 1986-04-08 | Fujisawa Pharmaceutical Co., Ltd. | Triazine derivatives, and pharmaceutical compositions comprising the same |
-
1982
- 1982-10-08 US US06/433,513 patent/US4616014A/en not_active Expired - Fee Related
- 1982-10-11 AU AU89269/82A patent/AU8926982A/en not_active Abandoned
- 1982-10-11 GR GR69503A patent/GR76714B/el unknown
- 1982-10-13 DK DK453882A patent/DK453882A/da not_active Application Discontinuation
- 1982-10-15 EP EP82109529A patent/EP0077983B1/fr not_active Expired
- 1982-10-15 DE DE8282109529T patent/DE3276164D1/de not_active Expired
- 1982-10-18 FI FI823544A patent/FI823544A7/fi not_active Application Discontinuation
- 1982-10-21 NO NO823506A patent/NO823506L/no unknown
- 1982-10-21 ES ES516724A patent/ES8401042A1/es not_active Expired
- 1982-10-22 JP JP57186641A patent/JPS5899468A/ja active Pending
- 1982-10-22 OA OA57828A patent/OA07236A/fr unknown
-
1983
- 1983-06-15 ES ES523300A patent/ES523300A0/es active Granted
- 1983-06-15 ES ES523299A patent/ES8601934A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES523299A0 (es) | 1985-04-16 |
| DK453882A (da) | 1983-04-23 |
| EP0077983B1 (fr) | 1987-04-29 |
| ES516724A0 (es) | 1983-11-16 |
| NO823506L (no) | 1983-04-25 |
| ES8401042A1 (es) | 1983-11-16 |
| FI823544A0 (fi) | 1982-10-18 |
| JPS5899468A (ja) | 1983-06-13 |
| ES8500247A1 (es) | 1984-10-01 |
| EP0077983A1 (fr) | 1983-05-04 |
| ES8601934A1 (es) | 1985-04-16 |
| AU8926982A (en) | 1983-04-28 |
| GR76714B (fr) | 1984-08-29 |
| DE3276164D1 (en) | 1987-06-04 |
| FI823544L (fi) | 1983-04-23 |
| ES523300A0 (es) | 1984-10-01 |
| US4616014A (en) | 1986-10-07 |
| FI823544A7 (fi) | 1983-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ712A1 (fr) | Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires. | |
| DZ2197A1 (fr) | Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2300A1 (fr) | Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2299A1 (fr) | Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ418A1 (fr) | Dérivés de céphalosporine, leur procédé de préparation et leur application thérapeutique. | |
| FR2708608B1 (fr) | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. | |
| DZ1889A1 (fr) | Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| FR2708606B1 (fr) | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. | |
| DZ2634A1 (fr) | Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant. | |
| OA08481A (fr) | Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant. | |
| NL950007I2 (nl) | 1,2,4-Triazinederivaten, werkwijze voor de bereiding van deze verbindingen, en deze verbindingen bevattende farmaceutische preparaten. | |
| OA08647A (fr) | Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant. | |
| DZ2188A1 (fr) | Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant. | |
| OA07003A (fr) | Préparation de nouveaux dérivés de la furo-(3,4-c) -pyridine. | |
| OA07699A (fr) | Dérivés de la furo-(3,4-c)-pyridine leur préparation et compositions thérapeutiques contenant ces dérivés. | |
| OA07766A (fr) | Procédé de préparation de dérivés de cephème. | |
| FR2716195B1 (fr) | Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant. | |
| FR2705095B1 (fr) | Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
| FI823544A7 (fi) | Triatsiinijohdokset, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset seokset. | |
| OA09442A (fr) | Dérivés de la thiéno-triazolo-diazépine, un procédé pour leur préparation et compositions thérapeutiques en contenant. | |
| DZ2309A1 (fr) | Dérivés de pyrrolidinyl-et pyrrolinyl-éthylamine procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| OA07390A (fr) | Nouveaux dérivés de carbapenem, compositions pharmaceutiques les contenant, composés intermédiaires pour leur préparation, et leurs procédés de production. | |
| FR2720397B1 (fr) | Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment. | |
| FR2712289B1 (fr) | Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
| IT8021370A0 (it) | Derivati teofillinmetildiossolanici, procedimenti per la loro preparazione e relative composizioni farmaceutiche. |